You are here : Home / Quarterly Results / SUN PHARMACEUTICAL INDUSTRIES LTD

SUN PHARMACEUTICAL INDUSTRIES Quarterly Results Analysis Q1FY22 [Jun2021]

Q-o-Q REVENUES OPERATING PROFIT PROFIT AFTER TAX EPS Updated : 20-Sep-21 Details👇

SUN PHARMACEUTICAL INDUSTRIES Quarterly Results

Consolidated Jun2021
Audited
Mar2021
Audited
Dec2020
UnAudited
Sep2020
UnAudited
Jun2020
Audited
Mar2020
Audited
Dec2019
UnAudited
Sep2019
UnAudited
Revenues ₹9,719 Cr ₹8,523 Cr ₹8,837 Cr ₹8,553 Cr ₹7,585 Cr ₹8,185 Cr ₹8,155 Cr ₹8,123 Cr
Expenses ₹6,978 Cr ₹6,475 Cr ₹6,502 Cr ₹6,360 Cr ₹5,821 Cr ₹6,822 Cr ₹6,395 Cr ₹6,342 Cr
Operating Income ₹2,741 Cr ₹2,048 Cr ₹2,335 Cr ₹2,193 Cr ₹1,764 Cr ₹1,363 Cr ₹1,760 Cr ₹1,781 Cr
Other Income ₹232 Cr ₹111 Cr ₹387 Cr ₹256 Cr ₹233 Cr ₹102 Cr ₹202 Cr ₹209 Cr
Interest ₹35 Cr ₹30 Cr ₹26 Cr ₹33 Cr ₹52 Cr ₹52 Cr ₹63 Cr ₹84 Cr
Depreciation ₹503 Cr ₹553 Cr ₹532 Cr ₹499 Cr ₹496 Cr ₹575 Cr ₹547 Cr ₹473 Cr
Profit Before Tax ₹1,804 Cr ₹903 Cr ₹2,163 Cr ₹1,917 Cr ₹-2,184 Cr ₹577 Cr ₹1,351 Cr ₹1,433 Cr
Profit After Tax ₹1,409 Cr ₹848 Cr ₹1,918 Cr ₹1,948 Cr ₹-2,430 Cr ₹494 Cr ₹1,024 Cr ₹1,167 Cr
EPS ₹6.02 ₹3.73 ₹7.72 ₹7.56 ₹-6.90 ₹1.67 ₹3.81 ₹4.44

Check out Industry Peers

Peers & Returns1W1M1Y
SUN PHARMACEUTICAL INDUSTRIES -2.7% 5.6% 69.1%
DIVIS LABORATORIES -4.8% -1.2% 67.8%
DR REDDYS LABORATORIES -4.9% -4.4% -8%
CIPLA -0.9% -7.1% 19.3%
GLAND PHARMA -1.5% -4.6% NA
PIRAMAL ENTERPRISES -8.1% -2% 102.9%
CADILA HEALTHCARE -6% -10.5% 20.8%
TORRENT PHARMACEUTICALS -4.6% -3.9% 12.5%
ALKEM LABORATORIES -3% -3.7% 42.9%

SUN PHARMACEUTICAL INDUSTRIES Quarterly Revenues

Revenues
Q-o-Q

14.03 %

Y-o-Y

28.13 %

Quarters Revenues % Change
Jun2021 ₹9,719 Cr
14.03
Mar2021 ₹8,523 Cr
-3.55
Dec2020 ₹8,837 Cr
3.32
Sep2020 ₹8,553 Cr
12.76
Jun2020 ₹7,585 Cr
-7.33
Mar2020 ₹8,185 Cr
0.37
Dec2019 ₹8,155 Cr
0.39
Sep2019 ₹8,123 Cr -

SUN PHARMACEUTICAL INDUSTRIES Quarterly Operating Profit

Operating Profit
Q-o-Q

33.82 %

Y-o-Y

55.37 %

Quarters Operating Profit % Change
Jun2021 ₹2,741 Cr
33.82
Mar2021 ₹2,048 Cr
-12.25
Dec2020 ₹2,335 Cr
6.44
Sep2020 ₹2,193 Cr
24.31
Jun2020 ₹1,764 Cr
29.45
Mar2020 ₹1,363 Cr
-22.54
Dec2019 ₹1,760 Cr
-1.21
Sep2019 ₹1,781 Cr -
Operating Margins
Q-o-Q

17.39 %

Y-o-Y

21.28 %

Quarters Operating Margin% % Change
Jun2021 28.21%
17.39
Mar2021 24.03%
-9.05
Dec2020 26.42%
3.04
Sep2020 25.64%
10.23
Jun2020 23.26%
39.70
Mar2020 16.65%
-22.85
Dec2019 21.58%
-1.60
Sep2019 21.93% -

SUN PHARMACEUTICAL INDUSTRIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

66.11 %

Y-o-Y

Positive

Quarters Profit After Tax % Change
Jun2021 ₹1,409 Cr
66.11
Mar2021 ₹848 Cr
-55.79
Dec2020 ₹1,918 Cr
-1.55
Sep2020 ₹1,948 Cr
Positive
Jun2020 ₹-2,430 Cr
Negative
Mar2020 ₹494 Cr
-51.71
Dec2019 ₹1,024 Cr
-12.30
Sep2019 ₹1,167 Cr -
PAT Margins
Q-o-Q

45.63 %

Y-o-Y

Positive

Quarters PAT Margin(%) % Change
Jun2021 14.49 %
45.63
Mar2021 9.95 %
-54.17
Dec2020 21.71 %
-4.70
Sep2020 22.78 %
Positive
Jun2020 -32.03 %
Negative
Mar2020 6.04 %
-51.87
Dec2019 12.55 %
-12.67
Sep2019 14.37 % -

SUN PHARMACEUTICAL INDUSTRIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

61.39 %

Y-o-Y

Positive

Quarters EPS % Change
Jun2021 ₹6.02
61.39
Mar2021 ₹3.73
-51.68
Dec2020 ₹7.72
2.12
Sep2020 ₹7.56
Positive
Jun2020 ₹-6.9
Negative
Mar2020 ₹1.67
-56.17
Dec2019 ₹3.81
-14.19
Sep2019 ₹4.44 -
STOCK RESEARCH & ANALYSIS Smart-Investing
LEARN VIA VIDEO COURSE Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

SUN PHARMACEUTICAL INDUSTRIES related INDICES

BSE Indices1W1M1Y
S&P BSE SENSEX -1.5% 3.2% 52.4%
S&P BSE SENSEX50 -2% 3.1% 54.5%
S&P BSE LARGECAP -2.3% 3.1% 55%
S&P BSE 100 LARGECAP TMC -2.4% 2.8% 55.6%
S&P BSE 100 ESG INDEX -2.5% 3.5% 55.9%
S&P BSE 100 -2.5% 2.8% 55.9%
S&P BSE CARBONEX -2.5% 3.2% 55.8%
S&P BSE LARGE MIDCAP -2.7% 2.9% 57.9%
S&P BSE 200 -2.7% 2.8% 58.9%
S&P BSE 250 LARGEMIDCAP -2.9% 2.7% 59.4%
S&P BSE 500 -3.1% 2.7% 61.2%
S&P BSE ALLCAP -3.2% 2.7% 62.3%
S&P BSE GREENEX -3.5% 4.4% 63.5%
S&P BSE DIVIDEND STABILITY -3.8% 6.3% 65%
S&P BSE HEALTHCARE -4.4% -5% 27.9%
S&P BSE 500 SHARIAH -4.9% -1.6% 53.4%
MFG -5% 1.6% 49.9%
NSE Indices1W1M1Y
NIFTY 50 -2% 3.2% 54.5%
NIFTY100 LIQ 15 -2.1% 3.9% 73.7%
NIFTY 100 -2.4% 2.6% 55.1%
NIFTY LARGE MIDCAP 250 -2.4% 4.3% 70.8%
NIFTY500 MULTICAP 50:25:25 -2.5% 4.2% NA
NIFTY 200 -2.8% 2.8% 58.7%
NIFTY 500 -3.1% 2.7% 60.9%
NIFTY50 EQUAL WEIGHT -3.2% 2.7% 71.4%
NIFTY HEALTHCARE -3.7% -3.1% NA
NIFTY 100 EQUAL WEIGHT -3.9% 1.1% 66.8%
NIFTY PHARMA -4.4% -2.7% 19.9%

You may also like the below Video Courses

Check out Intrinsic Value of Industry Peers
Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES LTD
Intrinsic Value of DIVIS LABORATORIES LTD
Intrinsic Value of DR REDDYS LABORATORIES LTD
Intrinsic Value of CIPLA LTD
Intrinsic Value of GLAND PHARMA LTD
Intrinsic Value of PIRAMAL ENTERPRISES LTD
Intrinsic Value of CADILA HEALTHCARE LTD
Intrinsic Value of TORRENT PHARMACEUTICALS LTD
Intrinsic Value of ALKEM LABORATORIES LTD
Intrinsic Value of LUPIN LTD
Intrinsic Value of AUROBINDO PHARMA LTD
Intrinsic Value of BIOCON LTD
Intrinsic Value of ABBOTT INDIA LTD
Intrinsic Value of LAURUS LABS LTD
Intrinsic Value of IPCA LABORATORIES LTD
Check out Annual Financials of Industry Peers
Share Price & Financials of SUN PHARMACEUTICAL INDUSTRIES LTD | BOM: 524715 | NSE: SUNPHARMA
Share Price & Financials of DIVIS LABORATORIES LTD | BOM: 532488 | NSE: DIVISLAB
Share Price & Financials of DR REDDYS LABORATORIES LTD | BOM: 500124 | NSE: DRREDDY
Share Price & Financials of CIPLA LTD | BOM: 500087 | NSE: CIPLA
Share Price & Financials of GLAND PHARMA LTD | BOM: 543245 | NSE: GLAND
Share Price & Financials of PIRAMAL ENTERPRISES LTD | BOM: 500302 | NSE: PEL
Share Price & Financials of CADILA HEALTHCARE LTD | BOM: 532321 | NSE: CADILAHC
Share Price & Financials of TORRENT PHARMACEUTICALS LTD | BOM: 500420 | NSE: TORNTPHARM
Share Price & Financials of ALKEM LABORATORIES LTD | BOM: 539523 | NSE: ALKEM
Share Price & Financials of LUPIN LTD | BOM: 500257 | NSE: LUPIN
Share Price & Financials of AUROBINDO PHARMA LTD | BOM: 524804 | NSE: AUROPHARMA
Share Price & Financials of BIOCON LTD | BOM: 532523 | NSE: BIOCON
Share Price & Financials of ABBOTT INDIA LTD | BOM: 500488 | NSE: ABBOTINDIA
Share Price & Financials of LAURUS LABS LTD | BOM: 540222 | NSE: LAURUSLABS
Share Price & Financials of IPCA LABORATORIES LTD | BOM: 524494 | NSE: IPCALAB

Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of GLAND PHARMA LTD
Market Cap of PIRAMAL ENTERPRISES LTD
Market Cap of CADILA HEALTHCARE LTD
Market Cap of TORRENT PHARMACEUTICALS LTD
Market Cap of ALKEM LABORATORIES LTD
Market Cap of LUPIN LTD
Market Cap of AUROBINDO PHARMA LTD
Market Cap of BIOCON LTD
Market Cap of ABBOTT INDIA LTD
Market Cap of LAURUS LABS LTD
Market Cap of IPCA LABORATORIES LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z